CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Intranasal insulin does not alter endogenous glucose production, but decreases liver fat and increases hepatic γATP in humans
DOI 10.1055/s-0034-1374880
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Gancheva, C Koliaki, A Bierwagen, P Nowotny, A Nagel, N Achterath, K Tinnes, M Eßer, A Fritsche, M Heni, HU Häring, J Szendrödi, M Roden
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe05/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Evidence from both rodents and humans indicates central role for brain insulin delivery on regulation of peripheral glucose and lipid metabolism. In the present study, we investigated the acute effects of intranasal insulin on endogenous glucose production (EGP) and hepatic energy metabolism in humans. Methods: Ten lean normoglycemic humans (age 25.7 ± 1.6yrs, BMI 23.1 ± 0.9 kg/m2, CON) and 10 patients w…
Zitieren
Zitierempfehlung
S Gancheva, C Koliaki, A Bierwagen, P Nowotny, A Nagel, N Achterath, K Tinnes, M Eßer, A Fritsche, M Heni, HU Häring, J Szendrödi, M Roden (2014) Intranasal insulin does not alter endogenous glucose production, but decreases liver fat and increases hepatic γATP in humans. Diabetologie und Stoffwechsel (05). https://doi.org/10.1055/s-0034-1374880
Mit CareLit weiterarbeiten